Jan 2021--The Groundbreaking Ceremony of Sinocare iPOCT Industrial Park Project is held.

Oct.2020---iPOCT standardization laboratory is marketed officially in CMEF Shanghai.

Jan,2019-- Innovative medical device portable multi-function analyzer liquid phase iPOCT: iCARE-2000/2100 was released at the annual conference of POCT 2019

May,2019-- AGEscan, a non-invasive diabetes risk screening product, was launched at the 81st CMEF, opening a new entrance to the whole course management of diabetes.

Nov, 2018-- China BEST EMPLOYER OUTSTANDING EMPLOYER AWARD

Nov, 2018-- Sinocare invested D-nurse to build an internet hospital

Jun. 2018-- Sinocare’s intelligent manufacturing technology has got the support of national special fund.

Jan .2018-- Sinocare has completed asset restructuring, PTS has become our wholly-owned subsidiary.

Oct. 2017-- Oct. 2017 Gold AQ Blood Glucose Monitoring System Has received U.S. FDA 510(K) clearance

July.2016-- Acquired PTS Diagnostics

Jan. 2016-- Acquired Nipro diagnostic Inc. (now renamed as Trividia Health Inc.), reaching the international leading Blood Glucose Monitor corporation

Aug. 2015-- "Sannuo" trademark has been recognized as a well-known trademark in China.

Oct. 2013-- Sinocare Biosensor Production Factory came into service

Sep. 2013 -- Mobile phone BGM received CFDA registration certificate, achieved a leap forward in services by establishing the model of “Monitoring-Evaluation-Intervention”, entering mHealth industry

Mar. 2012-- Listed on SZSE (Shenzhen Stock Exchange)

Mar. 2008-- Approved by NDRC (National Development and Reform Commission) as “Biomedical Engineering Model Project”

Dec. 2007-- Involved in China-Cuba Biotechnology Cooperation Framework, entering into market of Latin America.

Feb. 2007-- Passed ISO13485 and CE Certificate

Jul. 2004--Sinocare Blood Glucose Monitoring System received Medical Device Registration Certificate

Nov. 2003--Awarded with National Innovation Support Fund